Back

Development of case definition criteria for querying insurance databases in heart failure epidemiological investigations: rationale and design of the HF-EPI-HUN study

11 May 2026 (16:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Epidemiology and registries Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Robert Sepp

University of Szeged, Szeged (Hungary)

5 More presentations in this session

Presentation thumbnail
Risk factor clusters driving hospitalization in heart failure
Assistant Professor M. Popescu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Clinical phenotype and treatment patterns according to age in patients hospitalised for heart failure
Mr M. Gutierrez Munoz (Getafe, ES)
Abstract Slides Video
Presentation thumbnail
Rationale and design of the turkiye heart failure (TURK-HF) registry
Doctor B. MURAT (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
efficacy and safety of mineralocorticoid receptor antagonists across geographical regions in heart failure: a patient-level pooled analysis
Doctor M. Chimura (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
A pan-European multi-level pathway mapping framework for heart failure and cardiovascular care
Mr D. Breucker (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology and registries

The Event

Event poster

Heart Failure 2026

11 May 2026 16:30 CET
You may be interested in
thumbnail
Congress Presentation
The epidemiology of heart failure in Hungary: basic data and temporal trends from the Hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)
thumbnail
Congress Presentation
Prevalence and incidence of heart failure in Hungary stratified by age and sex: data from the Hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)
thumbnail
Congress Presentation
Comorbidities in heart failure: data from the hungarian nationwide epidemiological study (HF-EPI-HUN) over a 15-year period (2009-2023)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources